Alexandre Wicky

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 180 citations · Full text

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

Jaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan et al. · Cancer Cell · 2021 · 176 citations · Full text

Tumor Immunology, Antitumor T Cells, Cancer Immunosurveillance +9

Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy

Marie Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker et al. · Science Immunology · 2021 · 77 citations · Full text

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

Prachi Bhave, Tasnia Ahmed, Serigne Lo et al. · Journal for ImmunoTherapy of Cancer · 2022 · 59 citations · Full text

The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study

Filipe Martins, Luis Schiappacasse, Marc Levivier et al. · Journal of Neuro-Oncology · 2019 · 35 citations · Full text

Neuro-oncology, Surgical Oncology, Radiation Therapy +10